Celebi, K. Et Al. 2014. THE ANTIPROTEINURIC EFFECT OF SITAGLIPTIN IN PATIENTS WITH DIABETIC NEPHROPATHY. 51st Congress of the European-Renal-Association(ERA)/European-Dialysis-and-Transplant-Association (EDTA) , (Amsterdam, Netherlands), 432.

Celebi, K., Sengul, E., Cekmen, M. B., & Yilmaz, A., (2014). THE ANTIPROTEINURIC EFFECT OF SITAGLIPTIN IN PATIENTS WITH DIABETIC NEPHROPATHY . 51st Congress of the European-Renal-Association(ERA)/European-Dialysis-and-Transplant-Association (EDTA) (pp.432). Amsterdam, Netherlands

Celebi, Koray Et Al. "THE ANTIPROTEINURIC EFFECT OF SITAGLIPTIN IN PATIENTS WITH DIABETIC NEPHROPATHY," 51st Congress of the European-Renal-Association(ERA)/European-Dialysis-and-Transplant-Association (EDTA), Amsterdam, Netherlands, 2014

Celebi, Koray Et Al. "THE ANTIPROTEINURIC EFFECT OF SITAGLIPTIN IN PATIENTS WITH DIABETIC NEPHROPATHY." 51st Congress of the European-Renal-Association(ERA)/European-Dialysis-and-Transplant-Association (EDTA) , Amsterdam, Netherlands, pp.432, 2014

Celebi, K. Et Al. (2014) . "THE ANTIPROTEINURIC EFFECT OF SITAGLIPTIN IN PATIENTS WITH DIABETIC NEPHROPATHY." 51st Congress of the European-Renal-Association(ERA)/European-Dialysis-and-Transplant-Association (EDTA) , Amsterdam, Netherlands, p.432.

@conferencepaper{conferencepaper, author={Koray Celebi Et Al. }, title={THE ANTIPROTEINURIC EFFECT OF SITAGLIPTIN IN PATIENTS WITH DIABETIC NEPHROPATHY}, congress name={51st Congress of the European-Renal-Association(ERA)/European-Dialysis-and-Transplant-Association (EDTA)}, city={Amsterdam}, country={Netherlands}, year={2014}, pages={432} }